We are live on ! Find out more
LI

LMCG Investments Portfolio holdings

AUM $1.87B
1-Year Est. Return 50.61%
This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+50.61%
3 Year Est. Return
+124.92%
5 Year Est. Return
10 Year Est. Return
AUM
$1.6B
AUM Growth
+$88.6M
Cap. Flow
-$48.8M
Cap. Flow %
-3.06%
Top 10 Hldgs %
27.87%
Holding
232
New
4
Increased
49
Reduced
146
Closed
7

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$13.2M
2
NOC icon
Northrop Grumman
NOC
+$9.09M
3
ZBH icon
Zimmer Biomet
ZBH
+$6.93M
4
NEM icon
Newmont
NEM
+$5.77M
5
ENPH icon
Enphase Energy
ENPH
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 26.6%
2 Financials 15.03%
3 Healthcare 10.3%
4 Industrials 8.69%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENPH icon
226
Enphase Energy
ENPH
$5.53B
-76,885
Closed -$4.77M
GEHC icon
227
GE HealthCare
GEHC
$32.4B
-2,571
Closed -$208K
GM icon
228
General Motors
GM
$76.8B
-61,293
Closed -$2.88M
IJR icon
229
iShares Core S&P Small-Cap ETF
IJR
$112B
-1,914
Closed -$200K
SNOW icon
230
Snowflake
SNOW
$115B
-1,676
Closed -$245K
VOO icon
231
Vanguard S&P 500 ETF
VOO
$1.01T
-908
Closed -$467K
ZBH icon
232
Zimmer Biomet
ZBH
$18.4B
-61,260
Closed -$6.93M

Similar funds

LMCG Investments's Q2 2025 Portfolio in Review

As of Q2 2025, LMCG Investments held 232 positions worth $1.6B, up 5.9% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

LMCG Investments withdrew a net $48.8M in Q2 2025, closing 7 positions and reducing 146 holdings. Its most notable exit was Zimmer Biomet, an estimated $6.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMCG Investments opened a new position in iShares Core S&P 500 ETF worth $1.03M.

  • LMCG Investments's largest Q2 2025 buy was iShares Core S&P 500 ETF: 1,652 shares worth $1.03M.
  • LMCG Investments added most to Regeneron Pharmaceuticals in Q2 2025, an estimated $10.7M increase.
  • LMCG Investments's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $13.2M.
  • LMCG Investments fully exited Zimmer Biomet in Q2 2025, selling an estimated $6.93M.
  • LMCG Investments's ten largest holdings make up 28% of its $1.6B portfolio in Q2 2025.
  • LMCG Investments opened 4 new positions and closed 7 in Q2 2025.
  • LMCG Investments's portfolio value rose 5.9% quarter-over-quarter to $1.6B.

Based on LMCG Investments's 13F filing for Q2 2025, filed 24 Jul 2025.